Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma
โ Scribed by Zhao, Ze-Kun; Dong, Ping; Gu, Jun; Chen, Lei; Zhuang, Ming; Lu, Wen-Jie; Wang, Dao-Rong; Liu, Ying-Bin
- Book ID
- 118302887
- Publisher
- S. Karger AG
- Year
- 2012
- Tongue
- English
- Weight
- 404 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1010-4283
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular
## Abstract ## BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and the care of these patients remains highly specialized and complex. Multiple treatment options are available for HCC but their use and effectiveness remain unknown. ## METHODS: Using
## Background: Telomerase activation is thought to be essential for the immortality of cancer cells. we measured telomerase activity in human liver samples, including hepatocellular carcinoma (hcc), and evaluated this assay as a tool for the diagnosis of hcc using 21-gauge (21-g)-needle biopsy spec